# License

## üñ•Ô∏è Code (MIT License)

Copyright (c) 2025 Heming Zhang and contributors

Permission is hereby granted, free of charge, to any person obtaining a copy  
of this software and associated documentation files (the "Software"), to deal  
in the Software without restriction, including without limitation the rights  
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell  
copies of the Software, and to permit persons to whom the Software is  
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all  
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR  
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,  
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE  
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER  
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,  
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE  
SOFTWARE.  

---

## üìë Dataset (DepMap Terms of Use)

The **Target-QA dataset** is derived from the **Broad Institute‚Äôs Cancer Dependency Map (DepMap)**.  
It is **not** covered by the MIT License.  

- The dataset is released **strictly for non-commercial, internal research and academic use**, in accordance with the official [DepMap Terms of Use](https://depmap.org/portal).  
- We **do not redistribute original DepMap files**. Instead, we provide **derived, non-identifiable annotations** and **processing scripts** so that users can download the source data directly from DepMap after accepting its terms.  
- The dataset must **not** be used for clinical or diagnostic applications, or for any **Commercial Use** (e.g., direct sale, incorporation into a product, or training/developing/enhancing ML/AI models beyond internal academic research).  
- Attribution to **DepMap** and the **Broad Institute** is required.  
